OTCQX:MRVFF - Post by User
Post by
VictorKonstanon Jul 26, 2012 12:20pm
260 Views
Post# 20155018
Covidien reports Third Quarter results today....
Covidien reports Third Quarter results today.... Check out Covidien Conference Call regarding results...." Pharmaceuticals sales of $501 million in the third quarter were virtually unchanged from last year’s third-quarter sales of $500 million. Operational sales growth in the quarter was 2%, as foreign exchange rate movement reduced the quarterly sales growth rate by two percentage points. Sales of Specialty Pharmaceuticals climbed sharply from those of a year ago, primarily due to the strong performance of the EXALGO® and PENNSAID® products. Sales of Active Pharmaceutical Ingredients were above those of the third quarter of 2011, led by higher sales of narcotics.